Silexion Therapeutics Corp. (SLXN)
0.3606
-0.03
(-8.50%)
USD |
NASDAQ |
Aug 24, 16:00
0.3602
0.00 (0.00%)
After-Hours: 20:00
Silexion Therapeutics Total Liabilities (Quarterly) : 4.202M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.202M |
| March 31, 2026 | 4.311M |
| December 31, 2025 | 4.612M |
| September 30, 2025 | 4.637M |
| June 30, 2025 | 5.677M |
| March 31, 2025 | 5.722M |
| December 31, 2024 | 6.852M |
| September 30, 2024 | 7.666M |
| June 30, 2024 | 3.428M |
| March 31, 2024 | 3.193M |
| December 31, 2023 | 2.255M |
| September 30, 2023 | 2.535M |
| Date | Value |
|---|---|
| June 30, 2023 | 2.266M |
| March 31, 2023 | 1.908M |
| December 31, 2022 | 1.306M |
| September 30, 2022 | 1.032M |
| June 30, 2022 | 0.701M |
| March 31, 2022 | 0.8228M |
| December 31, 2021 | 0.5089M |
| September 30, 2021 | 0.4219M |
| June 30, 2021 | 0.4308M |
| March 31, 2021 | 0.3973M |
| December 31, 2020 | 0.2994M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BioLineRx Ltd. | 17.96M |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 113.60M |
| Can-Fite BioPharma Ltd. | -- |
| Galmed Pharmaceuticals Ltd. | 2.079M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.246M |
| Shareholders Equity (Quarterly) | 0.044M |
| Debt to Equity Ratio | 32.05 |
| Current Ratio | 0.9409 |
| Net Debt Paydown Yield | 13.77% |